• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.75/15; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.75/15; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419115
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 02/12/2021
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
In context of a dapt study, an orsiro mission drug-eluting stent was implanted.4 days after the index procedure patient suffered from chest pain.An electrocardiogram was performed which revealed an anterior shift.Patient underwent a cag which showed a stent thrombosis in the index lesion.
 
Manufacturer Narrative
Combination product: yes.Four days after the index procedure patient suffered from chest pain.An electrocardiogram was performed which revealed acute coronary syndrome with st segment elevation.Coronary angioplasty revealed acute intra-stent thrombotic occlusion of the previously implanted stent.Finally, the attempt to remove the blockage was not successful due to a semi-recent thrombosis not allowing passage of the guidewire.Decision for continuation of medical treatment.The device itself was not returned and could therefore not be subjected to a technical investigation.However, review of the product release documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation no device deficiency or manufacturing related root cause could be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 2.75/15
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key11595548
MDR Text Key243144906
Report Number1028232-2021-01539
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/07/2022
Device Model Number419115
Device Catalogue NumberSEE MODEL NO.
Device Lot Number12190322
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/30/2021
Initial Date FDA Received03/31/2021
Supplement Dates Manufacturer Received09/27/2021
Supplement Dates FDA Received09/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-